0001382963-17-000128.txt : 20170810
0001382963-17-000128.hdr.sgml : 20170810
20170810142520
ACCESSION NUMBER: 0001382963-17-000128
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170810
DATE AS OF CHANGE: 20170810
EFFECTIVENESS DATE: 20170810
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioQ Pharma Inc
CENTRAL INDEX KEY: 0001278320
IRS NUMBER: 000000000
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-292569
FILM NUMBER: 171020973
BUSINESS ADDRESS:
STREET 1: 185 BERRY STREET
STREET 2: SUITE 160
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: 4159750805
MAIL ADDRESS:
STREET 1: 185 BERRY STREET
STREET 2: SUITE 160
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
FORMER COMPANY:
FORMER CONFORMED NAME: BIOQUIDDITY INC
DATE OF NAME CHANGE: 20040202
D
1
primary_doc.xml
X0708
D
LIVE
0001278320
BioQ Pharma Inc
185 BERRY STREET
SUITE 160
SAN FRANCISCO
CA
CALIFORNIA
94107
4159750805
CALIFORNIA
BIOQUIDDITY INC
Corporation
true
Joshua
W.
Kriesel
185 Berry Street, Suite 160
San Francisco
CA
CALIFORNIA
94107
Executive Officer
Director
Ron
Pauli
185 Berry Street, Suite 160
San Francisco
CA
CALIFORNIA
94107
Executive Officer
Norvall
William
Jasper, Jr.
185 Berry Street, Suite 160
San Francisco
CA
CALIFORNIA
94107
Director
Mark
J.
Ehlert
185 Berry Street, Suite 160
San Francisco
CA
CALIFORNIA
94107
Director
Richard
Nesbit
185 Berry Street, Suite 160
San Francisco
CA
CALIFORNIA
94107
Director
Llew
Keltner
185 Berry Street, Suite 160
San Francisco
CA
CALIFORNIA
94107
Director
Christopher
Portman
185 Berry Street, Suite 160
San Francisco
CA
CALIFORNIA
94107
Director
Daniel
Tasse
185 Berry Street, Suite 160
San Francisco
CA
CALIFORNIA
94107
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2017-08-09
false
true
true
false
0
6250000
6250000
0
false
2
0
0
0
false
BioQ Pharma Inc
/S/JOSHUA W. KRIESEL
JOSHUA W. KRIESEL
CHIEF EXECUTIVE OFFICER AND PRESIDENT
2017-08-09